Fingerprint
Dive into the research topics of 'Weekly moxifloxacin and rifapentine is more active than the Denver regimen in murine tuberculosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Weekly moxifloxacin and rifapentine is more active than the Denver regimen in murine tuberculosis
Ian M. Rosenthal, Kathy Williams, Sandeep Tyagi, Andrew A. Vernon, Charles A. Peloquin, William R. Bishai, Jacques H. Grosset, Eric L. Nuermberger
Research output: Contribution to journal › Article › peer-review
53
Scopus
citations